Factors Associated with Recurrence of Amblyopia on Cessation of Patching

Jonathan M Holmes, Michele Melia, Yasmin S. Bradfield, Oscar A. Cruz, Brian Forbes

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: In a prospective observational study, we previously reported that weaning (tapering or gradually reducing) treatment in children treated with 6 to 8 hours of daily patching for amblyopia resulted in a 4-fold reduction in odds of recurrence. We now report the association of additional factors with recurrence or regression of amblyopia in this same cohort. Design: Prospective, nonrandomized, observational study. Participants: Sixty-nine children aged <8 years with successfully treated anisometropic or strabismic amblyopia (improved ≥3 logarithm of the minimum angle of resolution [logMAR] lines). Methods: Patients were enrolled at the time they stopped patching for amblyopia. Patients were classified according to whether patching was stopped abruptly or weaned before cessation. They were followed off treatment for 52 weeks to assess recurrence of amblyopia. Main Outcome Measure: Recurrence of amblyopia defined as a ≥2-logMAR level reduction of visual acuity from enrollment (cessation of patching) confirmed by a second examination. Recurrence was also considered to have occurred if treatment was restarted with a ≥2-logMAR level reduction of visual acuity, even if it was not confirmed by a second examination. Results: The risk of recurrence was higher with better visual acuity at the time of cessation of treatment (adjusted risk ratio [RR], 0.68 per line of worse visual acuity; 95% confidence interval [CI], 0.51-0.90), a greater number of lines improved during the previous treatment (adjusted RR, 1.5 per line increase; 95% CI, 1.1-2.0), and a history of recurrence (adjusted RR, 2.7; 95% CI, 1.5-4.9). Orthotropia or excellent stereoacuity at the time of patching cessation did not appear to have a protective effect on the risk of recurrence. Conclusions: The higher risk of recurrence in the most successfully treated children with amblyopia and absence of protection from orthotropia and excellent random dot stereoacuity suggests that careful and prolonged follow-up is needed for all children who have been previously treated for amblyopia.

Original languageEnglish (US)
Pages (from-to)1427-1432
Number of pages6
JournalOphthalmology
Volume114
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Amblyopia
Recurrence
Visual Acuity
Odds Ratio
Confidence Intervals
Observational Studies
Withholding Treatment
Therapeutics
Weaning
Outcome Assessment (Health Care)
Prospective Studies

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Factors Associated with Recurrence of Amblyopia on Cessation of Patching. / Holmes, Jonathan M; Melia, Michele; Bradfield, Yasmin S.; Cruz, Oscar A.; Forbes, Brian.

In: Ophthalmology, Vol. 114, No. 8, 08.2007, p. 1427-1432.

Research output: Contribution to journalArticle

Holmes, Jonathan M ; Melia, Michele ; Bradfield, Yasmin S. ; Cruz, Oscar A. ; Forbes, Brian. / Factors Associated with Recurrence of Amblyopia on Cessation of Patching. In: Ophthalmology. 2007 ; Vol. 114, No. 8. pp. 1427-1432.
@article{4fa8ab1ada254e26b19fbc97334e0322,
title = "Factors Associated with Recurrence of Amblyopia on Cessation of Patching",
abstract = "Purpose: In a prospective observational study, we previously reported that weaning (tapering or gradually reducing) treatment in children treated with 6 to 8 hours of daily patching for amblyopia resulted in a 4-fold reduction in odds of recurrence. We now report the association of additional factors with recurrence or regression of amblyopia in this same cohort. Design: Prospective, nonrandomized, observational study. Participants: Sixty-nine children aged <8 years with successfully treated anisometropic or strabismic amblyopia (improved ≥3 logarithm of the minimum angle of resolution [logMAR] lines). Methods: Patients were enrolled at the time they stopped patching for amblyopia. Patients were classified according to whether patching was stopped abruptly or weaned before cessation. They were followed off treatment for 52 weeks to assess recurrence of amblyopia. Main Outcome Measure: Recurrence of amblyopia defined as a ≥2-logMAR level reduction of visual acuity from enrollment (cessation of patching) confirmed by a second examination. Recurrence was also considered to have occurred if treatment was restarted with a ≥2-logMAR level reduction of visual acuity, even if it was not confirmed by a second examination. Results: The risk of recurrence was higher with better visual acuity at the time of cessation of treatment (adjusted risk ratio [RR], 0.68 per line of worse visual acuity; 95{\%} confidence interval [CI], 0.51-0.90), a greater number of lines improved during the previous treatment (adjusted RR, 1.5 per line increase; 95{\%} CI, 1.1-2.0), and a history of recurrence (adjusted RR, 2.7; 95{\%} CI, 1.5-4.9). Orthotropia or excellent stereoacuity at the time of patching cessation did not appear to have a protective effect on the risk of recurrence. Conclusions: The higher risk of recurrence in the most successfully treated children with amblyopia and absence of protection from orthotropia and excellent random dot stereoacuity suggests that careful and prolonged follow-up is needed for all children who have been previously treated for amblyopia.",
author = "Holmes, {Jonathan M} and Michele Melia and Bradfield, {Yasmin S.} and Cruz, {Oscar A.} and Brian Forbes",
year = "2007",
month = "8",
doi = "10.1016/j.ophtha.2006.11.023",
language = "English (US)",
volume = "114",
pages = "1427--1432",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Factors Associated with Recurrence of Amblyopia on Cessation of Patching

AU - Holmes, Jonathan M

AU - Melia, Michele

AU - Bradfield, Yasmin S.

AU - Cruz, Oscar A.

AU - Forbes, Brian

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: In a prospective observational study, we previously reported that weaning (tapering or gradually reducing) treatment in children treated with 6 to 8 hours of daily patching for amblyopia resulted in a 4-fold reduction in odds of recurrence. We now report the association of additional factors with recurrence or regression of amblyopia in this same cohort. Design: Prospective, nonrandomized, observational study. Participants: Sixty-nine children aged <8 years with successfully treated anisometropic or strabismic amblyopia (improved ≥3 logarithm of the minimum angle of resolution [logMAR] lines). Methods: Patients were enrolled at the time they stopped patching for amblyopia. Patients were classified according to whether patching was stopped abruptly or weaned before cessation. They were followed off treatment for 52 weeks to assess recurrence of amblyopia. Main Outcome Measure: Recurrence of amblyopia defined as a ≥2-logMAR level reduction of visual acuity from enrollment (cessation of patching) confirmed by a second examination. Recurrence was also considered to have occurred if treatment was restarted with a ≥2-logMAR level reduction of visual acuity, even if it was not confirmed by a second examination. Results: The risk of recurrence was higher with better visual acuity at the time of cessation of treatment (adjusted risk ratio [RR], 0.68 per line of worse visual acuity; 95% confidence interval [CI], 0.51-0.90), a greater number of lines improved during the previous treatment (adjusted RR, 1.5 per line increase; 95% CI, 1.1-2.0), and a history of recurrence (adjusted RR, 2.7; 95% CI, 1.5-4.9). Orthotropia or excellent stereoacuity at the time of patching cessation did not appear to have a protective effect on the risk of recurrence. Conclusions: The higher risk of recurrence in the most successfully treated children with amblyopia and absence of protection from orthotropia and excellent random dot stereoacuity suggests that careful and prolonged follow-up is needed for all children who have been previously treated for amblyopia.

AB - Purpose: In a prospective observational study, we previously reported that weaning (tapering or gradually reducing) treatment in children treated with 6 to 8 hours of daily patching for amblyopia resulted in a 4-fold reduction in odds of recurrence. We now report the association of additional factors with recurrence or regression of amblyopia in this same cohort. Design: Prospective, nonrandomized, observational study. Participants: Sixty-nine children aged <8 years with successfully treated anisometropic or strabismic amblyopia (improved ≥3 logarithm of the minimum angle of resolution [logMAR] lines). Methods: Patients were enrolled at the time they stopped patching for amblyopia. Patients were classified according to whether patching was stopped abruptly or weaned before cessation. They were followed off treatment for 52 weeks to assess recurrence of amblyopia. Main Outcome Measure: Recurrence of amblyopia defined as a ≥2-logMAR level reduction of visual acuity from enrollment (cessation of patching) confirmed by a second examination. Recurrence was also considered to have occurred if treatment was restarted with a ≥2-logMAR level reduction of visual acuity, even if it was not confirmed by a second examination. Results: The risk of recurrence was higher with better visual acuity at the time of cessation of treatment (adjusted risk ratio [RR], 0.68 per line of worse visual acuity; 95% confidence interval [CI], 0.51-0.90), a greater number of lines improved during the previous treatment (adjusted RR, 1.5 per line increase; 95% CI, 1.1-2.0), and a history of recurrence (adjusted RR, 2.7; 95% CI, 1.5-4.9). Orthotropia or excellent stereoacuity at the time of patching cessation did not appear to have a protective effect on the risk of recurrence. Conclusions: The higher risk of recurrence in the most successfully treated children with amblyopia and absence of protection from orthotropia and excellent random dot stereoacuity suggests that careful and prolonged follow-up is needed for all children who have been previously treated for amblyopia.

UR - http://www.scopus.com/inward/record.url?scp=34547171613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547171613&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2006.11.023

DO - 10.1016/j.ophtha.2006.11.023

M3 - Article

VL - 114

SP - 1427

EP - 1432

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -